The effect of saffron on patients with chemotherapy-induced neuropathy
Not Applicable
Recruiting
- Conditions
- Chemotherapy-induced nephropathy.Drug-induced polyneuropathy
- Registration Number
- IRCT20180119038433N1
- Lead Sponsor
- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with chemotherapy-induced neuropathy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of neuropathy (based on items in the questionnaire) of patients receiving chemotherapy. Timepoint: Evaluation of neuropathy in patients before administration of medication is between the administration period (day 45 after the intervention, ie the administration of the first dose, placebo and positive control) and after treatment (up to 1 month after the last administration of the intervention). Method of measurement: Nerve conduction velocity test as well as questionnaire.
- Secondary Outcome Measures
Name Time Method ife quality Score. Timepoint: Prior to prescribing, between the administration period (45 days after the intervention, ie the administration of the first dose, placebo and positive control) and after treatment (up to 1 month after the last administration of the interventions). Method of measurement: Short questionnaire 12 questions (SF12).